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Abstract. Bilirubin, a breakdown product of heme, is normally
glucuronidated and excreted by the liver into bile. Failure of this sys-
tem can lead to a buildup of conjugated bilirubin in the blood, resulting
in jaundice. The mechanistic basis of bilirubin excretion and hyperbil-
irubinemia syndromes is largely understood, but that of Rotor
syndrome, an autosomal recessive disorder characterized by conju-
gated hyperbilirubinemia, coproporphyrinuria, and near-absent
hepatic uptake of anionic diagnostics, has remained enigmatic. Here,
we analyzed 8 Rotor-syndrome families and found that Rotor
syndrome was linked to mutations predicted to cause complete and
simultaneous deﬁciencies of the organic anion transporting polypep-
tides OATP1B1 and OATP1B3. These important detoxiﬁcation-limiting
proteins mediate uptake and clearance of countless drugs and drug
conjugates across the sinusoidal hepatocyte membrane. OATP1B1
polymorphisms have previously been linked to drug hypersensitivities.
Using mice deﬁcient in Oatp1a/1b and in the multispeciﬁc sinusoidal
export pump Abcc3, we found that Abcc3 secretes bilirubin conjugates
into the blood, while Oatp1a/1b transporters mediate their hepatic
reuptake. Transgenic expression of human OATP1B1 or OATP1B3
restored the function of this detoxiﬁcation-enhancing liver-blood
shuttle in Oatp1a/1b-deﬁcient mice. Within liver lobules, this shuttle
may allow ﬂexible transfer of bilirubin conjugates (and probably
also drug conjugates) formed in upstreamhepatocytes to downstream
hepatocytes, thereby preventing local saturation of further
detoxiﬁcation processes and hepatocyte toxic injury. Thus, disruptionJournal of Hepatology 20
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and OATP1B3 deﬁciencies explains Rotor-type hyperbilirubinemia.
Moreover, OATP1B1 and OATP1B3 null mutations may confer
substantial drug toxicity risks.
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In 1975, one of us reported a case of hereditary hyperbilirubina-
emia,withpredominantly conjugatedbilirubin. Bromosulfophtha-
lein (BSP) hepatic storage capacity (S) was markedly reduced,
while BSP biliary transport maximum (Tm), reﬂecting excretory
capacity, was only moderately decreased, suggesting an uptake
and/or storage defect, rather than an excretory defect [1]. This
appeared to be a ‘‘new’’ syndrome, named hepatic uptake and
storage disease (OMIM 237550), since Rotor (OMIM #237450)
and Dubin–Johnson (OMIM #237500) syndromes, the two main
causes of hereditary conjugated hyperbilirubinaemia [2], were
considered, at that time, excretory defects, because of the presence
of conjugated bilirubin in blood. After this ﬁrst description, several
groups, including ours, re-examined patientswith Rotor and found
a markedly decreased BSP uptake and storage capacity, while BSP
biliary Tmwas relatively normal [3,4]. Since Rotor and uptake and
storagediseasepatientshada decreasedBSP storage capacity anda
relatively normal BSP Tm, Rotor and uptake and storage disease
were considered to be the same entity [5].
Since then, considerable progress has been made in the under-
standing of hepatic transporters and in the pathophysiology of
hyperbilirubinaemia. It has been conﬁrmed that Rotor syndrome
cannot be explained by an excretory defect, since no mutations of
ABCC2, the canalicular export pump for bilirubin glucuronide and
other organic anions, have been found [6]. But, in spite of these
advances, the reason why serum bilirubin in these patients,
was predominantly conjugated remains an enigma.
The recent work of van de Steeg et al. probably resolves this
mystery [7]. The authorswere investigating the role of the sinusoi-
dal organic anions transporting polypetides (OATPs, genes: SLCOs),
which mediate the hepatic uptake of a variety of compounds,
including bilirubin glucuronide, bile acids, steroid and thyroid
hormones, and numerous drugs, toxins and their conjugates. In
man, OATP1B1 and OATP1B3 are of particular importance, since
they mediate hepatic uptake of a number of drugs [8]. To further
study these transporters, van de Steeg et al. generated a Slco1a/
1b/ mouse model and noted that these mice exhibited
marked conjugated hyperbilirubinaemia. They postulated that
sinusoidal Oatps in the normal mouse function in ‘‘tandem’’ with
the sinusoidal efﬂux transporter Abcc3 (the sinusoidal equivalent13 vol. 58 j 388–390
Alb Ligandin
UCB UCB
BG
BG
BG
Blood Hepatocyte Bile
?
Bile
canaliculus
ABCC3
UGT1A1
MRP2/ABCC2
ABCG2
OATP1B1/3
Alb Ligandin
UCB UCB
BG
BG
BG
BG
Blood Hepatocyte Bile
?
Bile
canaliculus
ABCC3
UGT1A1
MRP2/ABCC2
ABCG2
OATP1B1/3
A B
Fig. 1. Hepatic transport of bilirubin in normal subjects (A) and in patients with Rotor syndrome (B). Normally, unconjugated bilirubin (UCB) is present in plasma
bound to albumin. It enters the hepatocyte mostly by passive diffusion across the sinusoidal membrane. Transporters like OATP1B1/3 or others (?) may also play a role. In
the hepatocyte, UCB is bound to ligandin, then conjugated into bilirubin glucuronide (BG) by the enzyme UDP-glucuronyl transferase 1A1 and excreted either into bile by
the canalicular conjugate export pump MRP2/ABCC2, or back into blood by the sinusoidal efﬂux carrier ABCC3. Finally, it is retaken up into the hepatocyte by the sinusoidal
transporters OATP1B1/3. In Rotor syndrome, OATP1B1/3 are defective, BG cannot re-enter the hepatocyte and accumulates in blood.
JOURNAL OF HEPATOLOGYof the canalicular conjugate export pump Abcc2) to mediate suc-
cessively hepatic efﬂux (by Abcc3) and reuptake (by Oatps) of bil-
irubin glucuronide. Their recent work is a combination of
functional studies inmice to test this hypothesis and genetic stud-
ies in humans to elucidate the genetic basis of Rotor syndrome. The
main results can be summarised as follows:Abcc3 mediates bilirubin glucuronide excretion from liver to
blood and Oatp1a/b mediate its hepatic reuptake
The authors generated double knockout mice whose Slco1a/b and
Abcc3 genes (coding, respectively, for the sinusoidal transporters
Oatp1a/b, functionally close to humanOATP1B1/3, andAbcc3, sim-
ilar to human ABCC3) were inactivated. The marked conjugated
hyperbilirubinaemia observed in Slco1a/b/mice (with only inac-
tive Oatp1a/b but functional Abcc3) [9] was absent or markedly
reduced in the double knockout mice (with inactive Oatp1a/b
and Abcc3). This shows that Abcc3 is necessary for most of the
increase in plasma conjugated bilirubin. The result is consistent
with the view that Abcc3 excretes bilirubin glucuronide back into
blood and Oatp1a/b mediate their hepatic reuptake.Human OATP1B1 and OATP1B3 effectively reuptake bilirubin
glucuronide from plasma to liver
Human hepatocytes express only two OATP1A/B proteins at the
sinusoidalmembrane:OATP1B1 andOATP1B3 [9]. To testwhether
these couldmediate bilirubinglucuronideuptake, the authors gen-
erated transgenic Slco1a/b/ ‘‘rescue’’ mice with liver speciﬁc
expression of either human OATP1B1 or OATP1B3. Both of the
transgenic ‘‘rescue’’ strains displayed a virtually complete reversal
of the increase in plasma and urine levels of bilirubin glucuronide
seen in the knockout Slco1a/b/ mice. This indicates that both
human OATP1B1 and OATP1B3 effectively reabsorb bilirubin glu-
curonide from plasma into the liver, in line with their known
in vitro role in bilirubin glucuronide uptake [9]. The modest
increase (1.8-fold) in plasma unconjugated bilirubin in Slco1a/
b/ mice was also reduced in the ‘‘rescue’’ strains, suggesting a
modest role of OATPs in hepatic unconjugated bilirubin uptake.Journal of Hepatology 201Pathogenic homozygous mutations of both SLCO1B1 and
SLCO1B3 are found in Rotor syndrome patients
Finally, the authors scanned the whole genome and mapped the
candidate gene intervals in 11 Rotor syndrome patients from8 dif-
ferent families (4 Central European, 3 Saudi-Arabian and 1 Fili-
pino). Homozygosity mapping identiﬁed a single genomic region
on chromosome 12 for which 8 tested index patients and no
healthy siblings were homozygous, suggesting inheritance of both
mutated alleles from a common ancestor. Sequence analysis
revealed predictably pathogenicmutations affecting both SLCO1B3
and SLCO1B1 in each of the tested subjects. The identiﬁed muta-
tions generally introduced a stop codon in the genes, thus severely
disrupting or, even, annihilating protein expression and function.
They all showed autosomal recessive segregation in the Rotor syn-
drome investigated families. The severity of the mutations was
supported by nearly absent immunostaining of OATP1B proteins
in liver biopsy specimens of Rotor syndrome patients.
In summary, in normal subjects (Fig. 1A), bilirubin, after entry
into hepatocytes, is conjugated into bilirubin glucuronide by
uridine glucuronyl transferase 1A1, and then excreted into bile
by the canalicular MRP2/ABCC2 conjugate export pump. In addi-
tion, this landmark study elegantly demonstrates that bilirubin
glucuronide is excreted back into blood by the sinusoidal protein
ABCC3, and then re-enters the hepatocyte via OATP1B1/3. The
authors propose that the reuptake process may occur in down-
streamhepatocytes (near the central vein) in order to prevent local
saturationof the transporters and tomaintain their efﬁcient detox-
iﬁcation function. In Rotor syndrome (Fig. 1B), mutations of the
OATP genes SLCO1B1/B3 lead to deﬁciency of the reuptake of
bilirubin conjugates and accumulation of conjugated bilirubin in
blood. This resolves the long-standing enigma of conjugated
hyperbilirubinaemia without any defect in conjugated bilirubin
excretion. Thus Rotor syndrome is clearly different from
Dubin–Johnson syndrome, which is due to a mutation of MRP2/
ABCC2 [7]. In Rotor, deﬁciency of OATP1B1/3 also explains the
marked impairment of BSP uptake and storage capacity, since
BSP is a substrate of these transporters [10].
It remains to be seen whether or not all patients classiﬁed as
Rotor or hepatic uptake and storage disease have the same3 vol. 58 j 388–390 389
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molecular defect. Let us hope that 37 years will not be necessary
to get an answer!Conﬂict of interest
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